3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Small Cell Lung Carcinoma
1
Sarcoma
1
Rectal Neoplasms
1
Plasmacytoma
1
Pancreatic Neoplasms
1
Neoplasms
1
Neoplasm Metastasis
1
Margins of Excision
1
Homologous Recombination Deficient Solid Tumors
1
Hematologic Neoplasms
1
Head and Neck Neoplasms
1
Drug-Related Side Effects and Adverse Reactions
1
Colorectal Neoplasms
1
Colonic Neoplasms
1
Carcinoma, Transitional Cell
1
Carcinoma, Non-Small-Cell Lung
1
Breast Neoplasms
1
Acrocephalosyndactylia
1
Interventions
Microscopy, Confocal
2
Indocyanine Green
2
Everolimus
2
varlilumab
1
Ultrasonography
1
Sunitinib
1
Simvastatin
1
Radiosurgery
1
Palliative Care
1
Neoadjuvant Therapy
1
Narrow Band Imaging
1
Interferon alpha-2
1
IFL protocol
1
Gastrectomy
1
Folfox protocol
1
Endoscopic Mucosal Resection
1
Drug Delivery Systems
1
Drug Combinations
1
Dermoscopy
1
Chemoradiotherapy
1
Bevacizumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Margins of Excision
×
Drug Combinations
×
Clear all
NCT04389086
2022-09-06
PelvEx II
Catharina Ziekenhuis Eindhoven
Phase 3
Recruiting
364 enrolled